Navigation Links
Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
Date:10/7/2008

U.S. National Institutes of Health, The Infectious Disease Research Institute and Eli Lilly and Company Announce Launch and Board of Advisors

SEATTLE, Oct. 7 /PRNewswire-FirstCall/ -- The Lilly TB Drug Discovery Initiative today announced its first acquisition of compounds for further development into tuberculosis (TB) drug candidates. Agreements were reached with Summit plc (LSE: SUMM) of Oxfordshire, UK, and the Microbial Chemistry Research Foundation (MCRF) of Tokyo for two compounds that have shown potential in initial testing.

The announcement marked the commencement of the Initiative's work and the opening of new laboratories focused on early drug discovery for TB. It also coincided with the first meeting of the non-profit organization's Board of Advisors and Scientific Steering Committee.

The Lilly TB Drug Discovery Initiative is a public-private partnership with the goal of filling the early-stage pipeline for future drug development. Created in June 2007, the Initiative's primary members are Eli Lilly and Company, the Infectious Disease Research Institute (IDRI), and the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH).

"I've seen first-hand the toll that TB takes on families in all corners of the world. People think of TB as a disease of the past, but with extensive spread of resistance to current drugs and without rapid development of new drugs, TB will be a disease of the future everywhere, including here in the U.S.," said Dr. Paul Farmer of Partners In Health and Harvard Medical School, who sits on the Initiative's Board of Advisors.

The access this public-private Initiative has to proprietary chemical libraries of compounds is unique. The Initiative will accelerate identification of new clinical candidates by bringing together specialists from around the world for the systematic exploration of vast, private molecular libraries. It will bring t
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. UPDATE: Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key
2. RG Global Corporate Update: First Coal Bed Methane Water Treatment Plant Near Completion; Expanding Water Treatment Applications
3. Update: Neurobiological Technologies Sets Date for Second Quarter Financial Results and Conference Call
4. Update: HYSTA Announces Dr. Qi Lu to Continue on as President of HYSTA, USA
5. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
6. Lilly Declares Fourth-Quarter Dividend
7. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
8. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
9. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
10. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
11. Lilly Announces Termination of AIR Insulin Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... With the ability to record continuously at ... than 15 minutes, Fastec Imaging has brought the same ease-of-use ... imaging. “Finally, a high speed camera that can be used ... everyday lives.” proclaims Matt Kearney, VP of Sales for Fastec ... demystify and simplify the traditionally complicated workflow of a high ...
(Date:7/23/2014)... 2014 a2z Inc. announces that AACC ... AACC Pathfinder, in its 2014 Annual Meeting & ... is planned for July 29-31, 2014 in Chicago, IL ... to connect with global leaders in clinical chemistry, molecular ... areas of breaking science in laboratory medicine. , ChirpE ...
(Date:7/23/2014)... July 23, 2014 Astra ... and comprehensive consultancy and pharma training services, and ... Safety (ACRES) , a non-profit integrating the expertise ... and maintain a global system for clinical trials, ... to improve the expertise of industry professionals through ...
(Date:7/22/2014)... LAKES, N.J. , July 22, 2014 The ... BDX ) has declared a quarterly dividend of ... to holders of record on September 9, 2014. The indicated ... About BD BD is a leading medical technology ... of the world,s most pressing and evolving health needs. Our ...
Breaking Biology Technology:Fastec Imaging Introduces the First High Speed Camcorder 2Fastec Imaging Introduces the First High Speed Camcorder 3AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 2AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 3Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 2Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 3
... University of Toronto materials science and engineering (MSE) ... key mechanism behind how energy levels align in ... is a significant breakthrough in the development of ... organic light-emitting diodes (OLEDs). Transition metal oxides, ...
... iBio, Inc. (NYSE AMEX: IBIO ) announced that ... Staff that the Company currently is below certain of the ... review of the Company,s Form 10-K for the year ended ... compliance with Section 1003(a)(iv) which applies if a listed company ...
... 4, 2011 Rosetta Genomics, Ltd. (NASDAQ: ... molecular diagnostics, announces that results from a joint study ... Rabin Medical Center, Beilinson Hospital and Golda-Hasharon Hospital in ... microRNAs may serve to predict the risk of recurrence. ...
Cached Biology Technology:iBio, Inc. Receives Notice from NYSE Amex Staff that Company Currently is Below Certain Continued Listing Standards 2Study Published in World Journal of Gastroenterology Shows Potential for microRNAs to Predict Gastric Cancer Recurrence 2Study Published in World Journal of Gastroenterology Shows Potential for microRNAs to Predict Gastric Cancer Recurrence 3Study Published in World Journal of Gastroenterology Shows Potential for microRNAs to Predict Gastric Cancer Recurrence 4Study Published in World Journal of Gastroenterology Shows Potential for microRNAs to Predict Gastric Cancer Recurrence 5Study Published in World Journal of Gastroenterology Shows Potential for microRNAs to Predict Gastric Cancer Recurrence 6
(Date:7/23/2014)... Migratory songbirds are disappearing, and though conservationists are examining ... habitat, acid rain and light pollution, a key piece ... birds go once they leave their breeding sites, and ... , To answer this question, a team of researchers ... migratory connectivity map produced for a songbird, using tracking ...
(Date:7/23/2014)... commonly found in dead bodies and is used in ... to as the post mortem interval. A report of ... Tamil Nadu is provided for the first time based ... DNA barcoding. This study, significant in forensic investigations was ... . , Chrysomya megacephala is commonly found ...
(Date:7/23/2014)... Rochelle, NY -- The potential for clinical use ... transplant-based therapeutic strategies has previously been hindered by ... development of tumors. The ability to use etoposide ... the treatment of heart disease, specifically acute myocardial ... Stem Cells and Development , a peer-reviewed journal ...
Breaking Biology News(10 mins):York University researchers use bird 'backpacks' to put wood thrushes migration on the map 2Dead body feeding larvae useful in forensic investigations 2
... award the 2008 Louisa Gross Horwitz Prize to ... the Department of Cellular Biochemistry at the Max ... Horwich, M.D., Eugene Higgins Professor of Genetics, professor ... (HHMI) investigator at Yale University School of Medicine, ...
... The National Association of Biology Teachers (NABT) will ... the University of Minnesota, with the 2008 Evolution Education ... 15-18 October 2008 in Memphis, Tennessee. ... Institute of Biological Sciences (AIBS) and the Biological Sciences ...
... Institute, working with collaborators at Tufts and Tuebingen ... stem cells, behavior. The researchers disrupted a natural ... trigged a cancer-like response, including increased cell growth, ... major body organs. This research shows that electrical ...
Cached Biology News:Columbia to award 2008 Horwitz Prize to Arthur Horwich & Ulrich Hartl for cellular protein folding 2Columbia to award 2008 Horwitz Prize to Arthur Horwich & Ulrich Hartl for cellular protein folding 3Columbia to award 2008 Horwitz Prize to Arthur Horwich & Ulrich Hartl for cellular protein folding 4Biologists, educators recognize excellence in evolution education 2Biologists, educators recognize excellence in evolution education 3Forsyth scientists trigger cancer-like response from embryonic stem cells 2
Mouse monoclonal [3B6] to HSV1 + HSV2 ICP5 Major Capsid Protein ( Abpromise for all tested applications)....
Mouse monoclonal [2Q2147] to Aequorin ( Abpromise for all tested applications)....
p21 Ras Immunogen: Recombinant C-H-ras p21(val-12). Storage: 4 C...
anti-Lactate Dehydrogenase...
Biology Products: